Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and Erythrocytosis

lenalidomide has been researched along with Erythrocytosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Cheng, CE; Cheng, M; Liang, B; Lor, M1
Liang, SH; Yeh, SP1
Arellano-Rodrigo, E1

Other Studies

3 other study(ies) available for lenalidomide and Erythrocytosis

ArticleYear
TEMPI Syndrome With Progressive Telangiectasias Associated With Pulmonary Deterioration.
    JAMA dermatology, 2020, 12-01, Volume: 156, Issue:12

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Bortezomib; Drug Therapy, Combination; Humans; Lenalidomide; Lung; Male; Middle Aged; Paraproteinemias; Polycythemia; Respiratory Insufficiency; Syndrome; Telangiectasis

2020
Relapsed multiple myeloma as TEMPI syndrome with good response to salvage lenalidomide and dexamethasone.
    Annals of hematology, 2019, Volume: 98, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Polycythemia; Recurrence; Salvage Therapy; Syndrome; Telangiectasis

2019
Case 23-2010: Unusual paraprotein effects in MGUS--treat or not?
    The New England journal of medicine, 2010, 11-04, Volume: 363, Issue:19

    Topics: Antineoplastic Agents; Humans; Kidney Diseases; Lenalidomide; Lymphangiectasis; Lymphangioma, Cystic; Paraproteinemias; Polycythemia; Thalidomide

2010